Yuyu Pharma Statistics
Total Valuation
Yuyu Pharma has a market cap or net worth of KRW 74.20 billion. The enterprise value is 85.58 billion.
Market Cap | 74.20B |
Enterprise Value | 85.58B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Yuyu Pharma has 16.18 million shares outstanding. The number of shares has increased by 5.80% in one year.
Shares Outstanding | 16.18M |
Shares Change (YoY) | +5.80% |
Shares Change (QoQ) | -8.90% |
Owned by Insiders (%) | 34.85% |
Owned by Institutions (%) | 0.29% |
Float | 10.54M |
Valuation Ratios
The trailing PE ratio is 44.02.
PE Ratio | 44.02 |
Forward PE | n/a |
PS Ratio | 0.56 |
PB Ratio | 0.64 |
P/FCF Ratio | 6.24 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.03, with an EV/FCF ratio of 7.19.
EV / Earnings | 49.57 |
EV / Sales | 0.63 |
EV / EBITDA | 7.03 |
EV / EBIT | 13.21 |
EV / FCF | 7.19 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.28.
Current Ratio | 1.63 |
Quick Ratio | 0.92 |
Debt / Equity | 0.28 |
Debt / EBITDA | 2.82 |
Debt / FCF | 3.00 |
Interest Coverage | 2.59 |
Financial Efficiency
Return on equity (ROE) is 3.81% and return on invested capital (ROIC) is 2.62%.
Return on Equity (ROE) | 3.81% |
Return on Assets (ROA) | 2.19% |
Return on Capital (ROIC) | 2.62% |
Revenue Per Employee | 534.71M |
Profits Per Employee | 6.82M |
Employee Count | 253 |
Asset Turnover | 0.68 |
Inventory Turnover | 1.86 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.92% in the last 52 weeks. The beta is 0.51, so Yuyu Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.51 |
52-Week Price Change | +4.92% |
50-Day Moving Average | 4,811.40 |
200-Day Moving Average | 4,954.08 |
Relative Strength Index (RSI) | 45.07 |
Average Volume (20 Days) | 50,792 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yuyu Pharma had revenue of KRW 135.28 billion and earned 1.73 billion in profits. Earnings per share was 104.17.
Revenue | 135.28B |
Gross Profit | 49.27B |
Operating Income | 6.97B |
Pretax Income | 4.90B |
Net Income | 1.73B |
EBITDA | 12.66B |
EBIT | 6.97B |
Earnings Per Share (EPS) | 104.17 |
Balance Sheet
The company has 36.22 billion in cash and 35.65 billion in debt, giving a net cash position of 562.60 million or 34.77 per share.
Cash & Cash Equivalents | 36.22B |
Total Debt | 35.65B |
Net Cash | 562.60M |
Net Cash Per Share | 34.77 |
Equity (Book Value) | 127.90B |
Book Value Per Share | 7,165.26 |
Working Capital | 39.84B |
Cash Flow
In the last 12 months, operating cash flow was 17.07 billion and capital expenditures -5.17 billion, giving a free cash flow of 11.90 billion.
Operating Cash Flow | 17.07B |
Capital Expenditures | -5.17B |
Free Cash Flow | 11.90B |
FCF Per Share | 735.25 |
Margins
Gross margin is 36.42%, with operating and profit margins of 5.15% and 1.92%.
Gross Margin | 36.42% |
Operating Margin | 5.15% |
Pretax Margin | 3.62% |
Profit Margin | 1.92% |
EBITDA Margin | 9.36% |
EBIT Margin | 5.15% |
FCF Margin | 8.80% |
Dividends & Yields
Yuyu Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.80% |
Shareholder Yield | -5.80% |
Earnings Yield | 2.27% |
FCF Yield | 16.04% |
Stock Splits
The last stock split was on March 30, 2021. It was a forward split with a ratio of 2.
Last Split Date | Mar 30, 2021 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Yuyu Pharma has an Altman Z-Score of 1.91. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.91 |
Piotroski F-Score | n/a |